课题基金 / 基金详情

The Skeletal Dysplasias

The Skeletal Dysplasias
骨骼发育不良
批准号:
7931042
负责人:
DAVID L RIMOIN
金额:
$5.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2010-09-29
关键词:

项目摘要

项目成果

DAVID L RIMOIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The skeletal dysplasias are a group of more than 370 disorders that result in disproportionate short stature and/or skeletal deformities. Although they have long been considered to be generalized disorders of endochondral and/or membranous ossification, the extent of their heterogeneity and genetic basis is still being elucidated and their pathogenesis can now be investigated. This program project is directed toward a multidisciplinary investigation of the clinical, genetic, morphologic, biochemical, and molecular characteristics of the skeletal dysplasias. Specific aims include: 1. Expansion of the materials for study in the International Skeletal Dysplasia Registry. 2. Definition of the clinical and radiographic features and genetic heterogeneity of the skeletal dysplasias and elucidation of the natural history, growth characteristics, and complications of each of these disorders. 3. Improvement of methods for the antenatal diagnosis of prenatal-onset skeletal dysplasias. 4. Elucidation of the histological, histochemical, immunohistological, and ultrastructural characteristics of chondroosseous tissue in each of the skeletal dysplasias. 5. Identification of the disease genes in osteochondrodysplasias of unknown etiology, using linkage, positional cloning, and candidate gene approaches. 6. Correlation of the clinical, radiographic, and morphologic features of each skeletal dysplasia with their specific biochemical and molecular defects. 7. Development of a new Protein Biochemistry Core to provide specialized analytical methods, including protein mass spectrometry, to characterize the protein defects in human and mouse skeletal dysplasias. 8. Evaluation of the effects of post-translational modification of proteins on chondroosseous development. The program project is consisted of two core facilities, the International Skeletal Dysplasia Registry and the Protein Biochemistry Core, plus three integrated projects; (1) Clinical, pathophysiological and therapeutic studies; (2) Molecular studies in the skeletal dysplasias; and (3) Developmental studies in the skeletal dysplasias. The International Skeletal Dysplasia Registry, the largest such registry/database in the world, serves as an international resource for studying the skeletal dysplasias. A worldwide group of referring health professionals provide materials from clinically documented cases for these research projects are integrated to define a comprehensive understanding of the biological basis of these conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE INTERNATIONAL SKELETAL DYSPLASIA REGISTRY
  • 批准号:
    8125466
  • 项目类别:
  • 资助金额:
    $20.91万
  • 财政年份:
    2010
  • 负责人:
    DAVID L RIMOIN
  • 依托单位:
CLINICAL TRIAL: TRIAL OF BETA BLOCKER THERAPY (ATENOLOL) VS ANGIOTENSIN II RECE
CLINICAL TRIAL: MUSCULOSKELETAL PHENOTYPE OF MARFAN PATIENTS
THE SKELETAL DYSPLASIA REGISTRY - GENETICS AND THE PATHOGENESIS
海外基金